Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stimuli-activatable PROTACs for precise protein degradation and cancer therapy
Jing Gao, Lei Yang, Shumin Lei, et al.
Science Bulletin (2023) Vol. 68, Iss. 10, pp. 1069-1085
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

New-generation advanced PROTACs as potential therapeutic agents in cancer therapy
Chao Wang, Yujing Zhang, Wujun Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 27
PROTAC Prodrug‐Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer
Shunan Zhang, Yi Lai, Jiaxing Pan, et al.
Advanced Materials (2024) Vol. 36, Iss. 23
Closed Access | Times Cited: 22
Nano-PROTACs: state of the art and perspectives
Jie Zhong, Ruiqi Zhao, Yuji Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 9, pp. 4378-4391
Closed Access | Times Cited: 18
Selective Protein of Interest Degradation through the Split-and-Mix Liposome Proteolysis Targeting Chimera Approach
Chunli Song, Zijun Jiao, Zhanfeng Hou, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 40, pp. 21860-21870
Closed Access | Times Cited: 23
Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy
Zhifeng Zou, Lei Yang, Hui-Jun Nie, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1740-1751
Closed Access | Times Cited: 14
Light‐Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy
Jiwoong Choi, Byeongmin Park, Jung Yeon Park, et al.
Advanced Materials (2024) Vol. 36, Iss. 38
Closed Access | Times Cited: 12
PROTAC-biomacromolecule conjugates for precise protein degradation in cancer therapy: A review
Chao Wang, Yujing Zhang, Wanpeng Yu, et al.
International Journal of Biological Macromolecules (2024) Vol. 261, pp. 129864-129864
Closed Access | Times Cited: 9
High‐Throughput Miniaturized Synthesis of PROTAC‐Like Molecules
Ye Tian, Maximilian Seifermann, Liana Bauer, et al.
Small (2024) Vol. 20, Iss. 26
Closed Access | Times Cited: 6
Self‐Oxygenating PROTAC Microneedle for Spatiotemporally‐Confined Protein Degradation and Enhanced Glioblastoma Therapy
Xingyu Jiang, Yi Lai, Wenzheng Xia, et al.
Advanced Materials (2025)
Open Access
Organelle-oriented nanomedicines in tumor therapy: Targeting, escaping, or collaborating?
Kexin Tan, Xiao‐Ai Zhang, Jian‐Yuan Yang, et al.
Bioactive Materials (2025) Vol. 49, pp. 291-339
Closed Access
Strategies for Precise Modulation of Protein Degradation
Shipeng He, Guoqiang Dong, Chunquan Sheng
Accounts of Chemical Research (2025)
Closed Access
Near‐Infrared‐II Nanomaterials for Activatable Photodiagnosis and Phototherapy
Wanying Jiang, Lisheng Lin, Ping Wu, et al.
Chemistry - A European Journal (2024) Vol. 30, Iss. 33
Closed Access | Times Cited: 3
Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple Negative Breast Cancer Treatment
Hongye He, Feng Li, Rui Tang, et al.
Biomaterials Research (2024) Vol. 2024
Open Access | Times Cited: 3
Conditional PROTAC: Recent Strategies for Modulating Targeted Protein Degradation
Junhyeong Yim, Jun‐Young Park, G. H. Kim, et al.
ChemMedChem (2024) Vol. 19, Iss. 22
Closed Access | Times Cited: 3
Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations
Zhijie Wang, Xun Lu, Canlin Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116237-116237
Closed Access | Times Cited: 2
Modular Development of Enzyme-Activatable Proteolysis Targeting Chimeras for Selective Protein Degradation and Cancer Targeting
Yanchi Chen, Lina Zhang, Lincheng Fang, et al.
JACS Au (2024) Vol. 4, Iss. 7, pp. 2564-2577
Open Access | Times Cited: 2
A photoactivatable upconverting nanodevice boosts the lysosomal escape of PROTAC degraders for enhanced combination therapy
Jiayin Zhan, Xiang Li, Yueru Mu, et al.
Biomaterials Science (2024) Vol. 12, Iss. 14, pp. 3686-3699
Closed Access | Times Cited: 2
Discovery of an activatable near-infrared fluorescent and theranostic PROTAC for tumor-targeted detecting and degrading of BRD4
Keliang Li, Guoqiang Dong, Shanchao Wu, et al.
Chinese Chemical Letters (2024), pp. 110280-110280
Closed Access | Times Cited: 2
Targeted protein degradation: current molecular targets, localization, and strategies
Dimanthi Pliatsika, Cindy Blatter, Rainer Riedl
Drug Discovery Today (2024), pp. 104178-104178
Open Access | Times Cited: 2
Dynamic polyphenol nanoparticles boost cuproptosis-driven metalloimmunotherapy of breast cancer
Huijuan Zhang, Fangmin Chen, Wen‐Hao Cheng, et al.
Nano Today (2024) Vol. 58, pp. 102442-102442
Closed Access | Times Cited: 1
Targeted protein degradation in hematologic malignancies: clinical progression towards novel therapeutics
Yupiao Feng, Xinting Hu, Xin Wang
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
MicroRNA‐Triggered Programmable DNA‐Encoded Pre‐PROTACs for Cell‐Selective and Controlled Protein Degradation
Jiayin Zhan, Xiang Li, Zhe Feng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access | Times Cited: 1
In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
Shaowen Xie, Jingjie Zhu, Yihan Peng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
Direct degradation and stabilization of proteins: New horizons in treatment of nonalcoholic steatohepatitis
Yibing Wang, Jianan Zheng, Yun‐Ze Long, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115989-115989
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top